Clinical trials

  • VERVE-201 for Refractory hyperlipidemia
  • PROPOFOL for Neurocritical illness
  • BNT329 for Advanced solid tumours | Pancreatic adenocarcinoma (PDAC) | Cholangiocarcinoma | Urothelial carcinoma | Colorectal adenocarcinoma | Ovarian epithelial cancer | Endometrial cancer | Adenocarcinoma of the gastroesophageal junction
  • Benzydamine hydrochloride for Non-streptococcal pharyngotonsillitis
  • Cefadroxil for Staphylococcus aureus bacteremia
  • Dermatophagoides pteronyssinus; Dermatophagoides farinae for Allergic rhinitis/rhinoconjunctivitis due to house dust mite (Dermatophagoides)
  • CILOSTAZOL for Migraine | Migraine without aura | Episodic migraine without aura
  • MK-4716 for Non-small cell lung cancer | Advanced or metastatic solid tumors with KRAS alterations
  • ATACICEPT for IgA nephropathy (IgAN) | Berger disease
  • Semaglutide for Type 2 diabetes mellitus|Cardiovascular disease|Overweight|Obesity
  • BAXDROSTAT for Chronic kidney disease|Hypertension
  • SACITUZUMAB TIRUMOTECAN for Metastatic cervical cancer (PD-L1 CPS ≥1)